US Stock MarketDetailed Quotes

Avita Medical (RCEL)

Watchlist
  • 4.380
  • +0.010+0.23%
Close May 12 16:00 ET
  • 4.380
  • 0.0000.00%
Post 16:10 ET
134.80MMarket Cap-2.52P/E (TTM)

Avita Medical (RCEL) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
36.26%-31.2M
32.71%-5.44M
27.65%-5.22M
19.96%-10.23M
50.59%-10.31M
-28.75%-48.94M
25.61%-8.08M
19.61%-7.21M
-40.42%-12.78M
-129.96%-20.86M
Net income from continuing operations
21.44%-48.59M
-0.28%-11.62M
18.62%-13.19M
35.56%-9.92M
25.72%-13.86M
-74.80%-61.85M
-64.03%-11.59M
-86.01%-16.21M
-48.24%-15.39M
-102.36%-18.66M
Operating gains losses
-492.29%-1.58M
-181.27%-612K
-72.75%224K
59.62%-825K
-141.84%-364K
104.70%402K
108.73%753K
1,074.29%822K
-22,800.00%-2.04M
43,600.00%870K
Depreciation and amortization
108.44%2.35M
71.15%700K
85.16%574K
170.59%552K
156.65%521K
78.16%1.13M
118.72%409K
89.02%310K
39.73%204K
50.37%203K
Other non cash items
-14.75%3.16M
54.52%649K
104.55%3.33M
-241.53%-1.09M
-68.50%280K
-19.48%3.71M
-86.31%420K
891.46%1.63M
34.20%773K
11.40%889K
Change In working capital
173.51%3.44M
640.88%4.04M
-59.73%952K
-3,407.84%-1.79M
103.86%241K
28.84%-4.68M
-24,966.67%-746K
181.27%2.36M
84.68%-51K
-87.26%-6.25M
-Change in receivables
187.65%3.63M
94.56%-81K
254.83%2.34M
198.72%1.63M
-150.30%-253K
-25.45%-4.15M
2.55%-1.49M
-826.92%-1.51M
-36.34%-1.65M
164.82%503K
-Change in inventory
78.33%-468K
117.69%198K
-52.94%144K
101.60%629K
13.26%-1.44M
41.51%-2.16M
13.12%-1.12M
121.83%306K
225.30%312K
-120.03%-1.66M
-Change in prepaid assets
306.47%766K
-46.02%509K
-125.00%-118K
-67.11%25K
118.80%350K
17.74%-371K
-41.28%943K
126.79%472K
124.76%76K
-15,616.67%-1.86M
-Change in payables and accrued expense
-96.20%107K
177.87%3M
-136.83%-1.29M
-255.03%-1.83M
107.67%225K
30.75%2.82M
-36.55%1.08M
2,604.65%3.49M
-52.76%1.18M
-34.60%-2.93M
-Change in other current assets
173.81%341K
46,300.00%464K
-80.77%-235K
-787.50%-639K
387.74%751K
62.77%-462K
100.21%1K
-247.73%-130K
65.71%-72K
58.90%-261K
-Change in other current liabilities
-25.77%-986K
79.25%-127K
401.23%1.72M
-853.30%-3.19M
2,560.00%615K
-75.39%-784K
17.74%-612K
-49.48%-571K
166.88%424K
-101.90%-25K
-Change in other working capital
-89.18%46K
-84.22%71K
-620.97%-1.62M
588.69%1.6M
0.00%-8K
4.68%425K
-39.11%450K
46.23%310K
-42.79%-327K
97.47%-8K
Cash from discontinued investing activities
Operating cash flow
36.26%-31.2M
32.71%-5.44M
27.65%-5.22M
19.96%-10.23M
50.59%-10.31M
-28.75%-48.94M
25.61%-8.08M
19.61%-7.21M
-40.42%-12.78M
-129.96%-20.86M
Investing cash flow
Cash flow from continuing investing activities
-66.67%12.45M
-99.55%11K
-172.23%-5.34M
-43.56%7.02M
-28.54%10.77M
2,225.02%37.36M
104.31%2.47M
-66.02%7.39M
-32.30%12.43M
-19.81%15.07M
Capital expenditure reported
---635K
----
----
----
----
--0
----
----
----
----
Net PPE purchase and sale
89.04%-1.01M
141.81%674K
75.16%-934K
80.24%-524K
80.73%-221K
-564.08%-9.17M
-444.59%-1.61M
-649.00%-3.76M
-786.96%-2.65M
-303.87%-1.15M
Net intangibles purchase and sale
38.89%-99K
-195.45%-65K
62.50%-21K
--0
84.34%-13K
-145.45%-162K
35.29%-22K
-460.00%-56K
80.00%-1K
-388.24%-83K
Net investment purchase and sale
-69.61%14.19M
-99.10%37K
-139.13%-4.39M
-50.02%7.54M
-32.50%11M
1,429.01%46.7M
107.21%4.11M
-49.67%11.21M
-19.19%15.09M
-14.63%16.3M
Cash from discontinued investing activities
Investing cash flow
-66.67%12.45M
-99.55%11K
-172.23%-5.34M
-43.56%7.02M
-28.54%10.77M
2,225.02%37.36M
104.31%2.47M
-66.02%7.39M
-32.30%12.43M
-19.81%15.07M
Financing cash flow
Cash flow from continuing financing activities
325.77%14.94M
-75.71%248K
1,267.03%13.77M
-34.16%559K
-42.47%363K
-91.31%3.51M
-97.41%1.02M
67.83%1.01M
396.49%849K
269.01%631K
Net issuance payments of debt
----
----
----
----
----
--0
----
----
----
----
Net common stock issuance
--14.79M
--0
----
----
----
--0
--0
----
----
----
Proceeds from stock option exercised by employees
-65.74%1.2M
-75.71%248K
-96.82%32K
-34.16%559K
-42.47%363K
117.62%3.51M
52.39%1.02M
67.83%1.01M
396.49%849K
269.01%631K
Net other financing activities
---1.06M
--0
----
----
----
----
----
----
----
----
Cash from discontinued financing activities
Financing cash flow
325.77%14.94M
-75.71%248K
1,267.03%13.77M
-34.16%559K
-42.47%363K
-91.31%3.51M
-97.41%1.02M
67.83%1.01M
396.49%849K
269.01%631K
Net cash flow
Beginning cash position
-36.48%14.05M
-17.26%15.42M
-30.00%12.22M
-12.28%14.87M
-36.48%14.05M
21.77%22.12M
-63.35%18.64M
-53.44%17.45M
-39.57%16.95M
21.77%22.12M
Current changes in cash
52.81%-3.81M
-12.86%-5.18M
170.09%3.21M
-629.74%-2.65M
115.87%820K
-303.22%-8.07M
84.03%-4.59M
-91.13%1.19M
-94.69%501K
-152.27%-5.17M
Effect of exchange rate changes
----
----
----
----
----
--0
--0
--0
--0
--0
End cash Position
-27.10%10.24M
-27.10%10.24M
-17.26%15.42M
-30.00%12.22M
-12.28%14.87M
-36.48%14.05M
-36.48%14.05M
-63.35%18.64M
-53.44%17.45M
-39.57%16.95M
Free cash flow
43.48%-32.93M
43.76%-5.46M
44.03%-6.17M
30.32%-10.75M
52.28%-10.54M
-47.68%-58.27M
13.20%-9.72M
-16.28%-11.03M
-64.09%-15.43M
-135.69%-22.09M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 36.26%-31.2M32.71%-5.44M27.65%-5.22M19.96%-10.23M50.59%-10.31M-28.75%-48.94M25.61%-8.08M19.61%-7.21M-40.42%-12.78M-129.96%-20.86M
Net income from continuing operations 21.44%-48.59M-0.28%-11.62M18.62%-13.19M35.56%-9.92M25.72%-13.86M-74.80%-61.85M-64.03%-11.59M-86.01%-16.21M-48.24%-15.39M-102.36%-18.66M
Operating gains losses -492.29%-1.58M-181.27%-612K-72.75%224K59.62%-825K-141.84%-364K104.70%402K108.73%753K1,074.29%822K-22,800.00%-2.04M43,600.00%870K
Depreciation and amortization 108.44%2.35M71.15%700K85.16%574K170.59%552K156.65%521K78.16%1.13M118.72%409K89.02%310K39.73%204K50.37%203K
Other non cash items -14.75%3.16M54.52%649K104.55%3.33M-241.53%-1.09M-68.50%280K-19.48%3.71M-86.31%420K891.46%1.63M34.20%773K11.40%889K
Change In working capital 173.51%3.44M640.88%4.04M-59.73%952K-3,407.84%-1.79M103.86%241K28.84%-4.68M-24,966.67%-746K181.27%2.36M84.68%-51K-87.26%-6.25M
-Change in receivables 187.65%3.63M94.56%-81K254.83%2.34M198.72%1.63M-150.30%-253K-25.45%-4.15M2.55%-1.49M-826.92%-1.51M-36.34%-1.65M164.82%503K
-Change in inventory 78.33%-468K117.69%198K-52.94%144K101.60%629K13.26%-1.44M41.51%-2.16M13.12%-1.12M121.83%306K225.30%312K-120.03%-1.66M
-Change in prepaid assets 306.47%766K-46.02%509K-125.00%-118K-67.11%25K118.80%350K17.74%-371K-41.28%943K126.79%472K124.76%76K-15,616.67%-1.86M
-Change in payables and accrued expense -96.20%107K177.87%3M-136.83%-1.29M-255.03%-1.83M107.67%225K30.75%2.82M-36.55%1.08M2,604.65%3.49M-52.76%1.18M-34.60%-2.93M
-Change in other current assets 173.81%341K46,300.00%464K-80.77%-235K-787.50%-639K387.74%751K62.77%-462K100.21%1K-247.73%-130K65.71%-72K58.90%-261K
-Change in other current liabilities -25.77%-986K79.25%-127K401.23%1.72M-853.30%-3.19M2,560.00%615K-75.39%-784K17.74%-612K-49.48%-571K166.88%424K-101.90%-25K
-Change in other working capital -89.18%46K-84.22%71K-620.97%-1.62M588.69%1.6M0.00%-8K4.68%425K-39.11%450K46.23%310K-42.79%-327K97.47%-8K
Cash from discontinued investing activities
Operating cash flow 36.26%-31.2M32.71%-5.44M27.65%-5.22M19.96%-10.23M50.59%-10.31M-28.75%-48.94M25.61%-8.08M19.61%-7.21M-40.42%-12.78M-129.96%-20.86M
Investing cash flow
Cash flow from continuing investing activities -66.67%12.45M-99.55%11K-172.23%-5.34M-43.56%7.02M-28.54%10.77M2,225.02%37.36M104.31%2.47M-66.02%7.39M-32.30%12.43M-19.81%15.07M
Capital expenditure reported ---635K------------------0----------------
Net PPE purchase and sale 89.04%-1.01M141.81%674K75.16%-934K80.24%-524K80.73%-221K-564.08%-9.17M-444.59%-1.61M-649.00%-3.76M-786.96%-2.65M-303.87%-1.15M
Net intangibles purchase and sale 38.89%-99K-195.45%-65K62.50%-21K--084.34%-13K-145.45%-162K35.29%-22K-460.00%-56K80.00%-1K-388.24%-83K
Net investment purchase and sale -69.61%14.19M-99.10%37K-139.13%-4.39M-50.02%7.54M-32.50%11M1,429.01%46.7M107.21%4.11M-49.67%11.21M-19.19%15.09M-14.63%16.3M
Cash from discontinued investing activities
Investing cash flow -66.67%12.45M-99.55%11K-172.23%-5.34M-43.56%7.02M-28.54%10.77M2,225.02%37.36M104.31%2.47M-66.02%7.39M-32.30%12.43M-19.81%15.07M
Financing cash flow
Cash flow from continuing financing activities 325.77%14.94M-75.71%248K1,267.03%13.77M-34.16%559K-42.47%363K-91.31%3.51M-97.41%1.02M67.83%1.01M396.49%849K269.01%631K
Net issuance payments of debt ----------------------0----------------
Net common stock issuance --14.79M--0--------------0--0------------
Proceeds from stock option exercised by employees -65.74%1.2M-75.71%248K-96.82%32K-34.16%559K-42.47%363K117.62%3.51M52.39%1.02M67.83%1.01M396.49%849K269.01%631K
Net other financing activities ---1.06M--0--------------------------------
Cash from discontinued financing activities
Financing cash flow 325.77%14.94M-75.71%248K1,267.03%13.77M-34.16%559K-42.47%363K-91.31%3.51M-97.41%1.02M67.83%1.01M396.49%849K269.01%631K
Net cash flow
Beginning cash position -36.48%14.05M-17.26%15.42M-30.00%12.22M-12.28%14.87M-36.48%14.05M21.77%22.12M-63.35%18.64M-53.44%17.45M-39.57%16.95M21.77%22.12M
Current changes in cash 52.81%-3.81M-12.86%-5.18M170.09%3.21M-629.74%-2.65M115.87%820K-303.22%-8.07M84.03%-4.59M-91.13%1.19M-94.69%501K-152.27%-5.17M
Effect of exchange rate changes ----------------------0--0--0--0--0
End cash Position -27.10%10.24M-27.10%10.24M-17.26%15.42M-30.00%12.22M-12.28%14.87M-36.48%14.05M-36.48%14.05M-63.35%18.64M-53.44%17.45M-39.57%16.95M
Free cash flow 43.48%-32.93M43.76%-5.46M44.03%-6.17M30.32%-10.75M52.28%-10.54M-47.68%-58.27M13.20%-9.72M-16.28%-11.03M-64.09%-15.43M-135.69%-22.09M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion with Explanatory Notes--------Unqualified Opinion--------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting an immediate response from Iran: no one Show More